Przemysław Przewratil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Przemysław Przewratil has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Adam Dobek
Department of Radiology and Diagnostic Imaging, Barlicki University Hospital, Medical University of Łódź, 90-153 Łódź, Poland
2 shared publications Ewa Andrzejewska
Department of Pediatric Surgery and Oncology, Medical University of Lodz
2 shared publications- Jakub Kopeć
Pediatric Surgery and Oncology Department, Medical University of Łódź, 90-419 Lodz, Poland
2 shared publications - Janusz Piotr Sikora
Department of Paediatric Emergency Medicine, 2nd Chair of Paediatrics, Central Clinical Hospital, Medical University of Łódź, ul. Sporna 36/50, 91-738 Łódź, Poland
2 shared publications - Jarosław Sobczak
Department of Paediatric Emergency Medicine, 2nd Chair of Paediatrics, Central Clinical Hospital, Medical University of Łódź, ul. Sporna 36/50, 91-738 Łódź, Poland
2 shared publications - Justyna Kukulska
Department of Pediatric Surgery and Oncology, Medical University of Lodz, 90-419 Lodz, Poland
2 shared publications
Latest Publications
- Open Access
Effects of Sirolimus Treatment in Children with Vascular Anomalies—A Single-Center Experience
Background: Vascular anomalies are rare congenital disorders associated with significant morbidity. Local therapies may be insufficient for complex lesions. Sirolimus, an mTOR inhibitor, is a promising systemic treatment option. Methods: We retrospectively analyzed pediatric patients with vascular anomalies treated with sirolimus between October 2020 and June 2025. Of 29 patients who initiated treatment, 23 completed at least 12 months of therapy and had evaluable 12-month outcomes; these patients constituted the primary 12-month efficacy cohort. Treatment discontinuations were analyzed separately, and an all-treated sensitivity analysis was performed. Results: The cohort included 10 patients (43%) with lymphatic malformations (LMs), 9 (39%) with venous malformations (VMs), 2 (9%) with combined malformations, and 2 (9%) with other vascular anomalies. At 12 months, magnetic resonance imaging (MRI) demonstrated lesion size reduction in 17/23 patients (74%), stabilization in 5/23 (22%), and progression in 1/23 patients (4%). In a conservative sensitivity analysis including all 29 treated patients and classifying patients without an evaluable 12-month outcome, documented reduction or stabilization was observed in 22/29 patients (76%). Additional treatment was less frequent during treatment (30% vs. 65%, p = 0.043), although observation periods differed. Pain decreased (p = 0.021), and physical activity increased (p = 0.034). No severe adverse events led to permanent treatment discontinuation. The most common adverse events were laboratory abnormalities (47%) and aphthous stomatitis (32%). Exploratory Multiple Factor Analysis (MFA) demonstrated substantial multidimensional heterogeneity but did not identify stable radiological response phenotypes. Conclusions: Sirolimus was associated with radiological improvement or stabilization, symptom relief, and fewer additional interventions in pediatric vascular anomalies, with generally favorable tolerability.
Open AccessEffects of Sirolimus Treatment in Children with Vascular Anomalies—A Single-Center Experience
Background: Vascular anomalies are rare congenital disorders associated with significant morbidity. Local therapies may be insufficient for complex lesions. Sirolimus, an mTOR inhibitor, is a promising systemic treatment option. Methods: We retrospectively analyzed pediatric patients with vascular anomalies treated with sirolimus between October 2020 and June 2025. Of 29 patients who initiated treatment, 23 completed at least 12 months of therapy and had evaluable 12-month outcomes; these patients constituted the primary 12-month efficacy cohort. Treatment discontinuations were analyzed separately, and an all-treated sensitivity analysis was performed. Results: The cohort included 10 patients (43%) with lymphatic malformations (LMs), 9 (39%) with venous malformations (VMs), 2 (9%) with combined malformations, and 2 (9%) with other vascular anomalies. At 12 months, magnetic resonance imaging (MRI) demonstrated lesion size reduction in 17/23 patients (74%), stabilization in 5/23 (22%), and progression in 1/23 patients (4%). In a conservative sensitivity analysis including all 29 treated patients and classifying patients without an evaluable 12-month outcome, documented reduction or stabilization was observed in 22/29 patients (76%). Additional treatment was less frequent during treatment (30% vs. 65%, p = 0.043), although observation periods differed. Pain decreased (p = 0.021), and physical activity increased (p = 0.034). No severe adverse events led to permanent treatment discontinuation. The most common adverse events were laboratory abnormalities (47%) and aphthous stomatitis (32%). Exploratory Multiple Factor Analysis (MFA) demonstrated substantial multidimensional heterogeneity but did not identify stable radiological response phenotypes. Conclusions: Sirolimus was associated with radiological improvement or stabilization, symptom relief, and fewer additional interventions in pediatric vascular anomalies, with generally favorable tolerability.
- Open Access
- 2 November 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 43 (1) , 4
Selected interleukins, soluble TNF-α receptors, c-reactive protein and cortisol as biomarkers of surgical trauma-induced inflammation in children
- 2 November 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 43 (1) , 4
Open AccessSelected interleukins, soluble TNF-α receptors, c-reactive protein and cortisol as biomarkers of surgical trauma-induced inflammation in children
- Open Access
Analysis of the Occurrence of PIK3CA Gene Mutation in Children with Lymphatic Malformation—Single Center Study
Background: Lymphatic malformations (LM) are rare congenital vascular anomalies caused by abnormal development and growth of lymphatic vessels. These malformations can lead to a wide range of symptoms, from mild swelling to more severe complications. Treatment options remain limited, especially for complex cases. Recent research has suggested that PIK3CA mutations play a key role in the pathogenesis of LM, potentially offering new possibilities for targeted treatment strategies. Methods: In this study, a cohort of 36 patients diagnosed with LM, Klippel-Trenaunay syndrome (KTS), and Proteus syndrome was analyzed. PIK3CA mutations were assessed in tissue samples obtained from the LM during clinically indicated procedures using digital droplet polymerase chain reaction (ddPCR), targeting five hotspots. Results: PIK3CA mutations were found in 18 patients (50%). The most frequent mutation was p.E542K (c.1624G>A), found in 19.44% of patients, followed by p.H1047R (c.3149A>G), p.E545K (c.1633G>A), and p.H1047L (c.3140A>T) each occurring in 11.11% of the cases. Mutations were more common in isolated LMs, with 63.16% of patients exhibiting PIK3CA mutations. Conclusions: PIK3CA mutations are common in LM, supporting the potential for targeted therapies like PI3K inhibitors in treating complex cases. This research highlights the importance of genetic analysis in the management of LM and offers a new therapeutic approach.
Open AccessAnalysis of the Occurrence of PIK3CA Gene Mutation in Children with Lymphatic Malformation—Single Center Study
Background: Lymphatic malformations (LM) are rare congenital vascular anomalies caused by abnormal development and growth of lymphatic vessels. These malformations can lead to a wide range of symptoms, from mild swelling to more severe complications. Treatment options remain limited, especially for complex cases. Recent research has suggested that PIK3CA mutations play a key role in the pathogenesis of LM, potentially offering new possibilities for targeted treatment strategies. Methods: In this study, a cohort of 36 patients diagnosed with LM, Klippel-Trenaunay syndrome (KTS), and Proteus syndrome was analyzed. PIK3CA mutations were assessed in tissue samples obtained from the LM during clinically indicated procedures using digital droplet polymerase chain reaction (ddPCR), targeting five hotspots. Results: PIK3CA mutations were found in 18 patients (50%). The most frequent mutation was p.E542K (c.1624G>A), found in 19.44% of patients, followed by p.H1047R (c.3149A>G), p.E545K (c.1633G>A), and p.H1047L (c.3140A>T) each occurring in 11.11% of the cases. Mutations were more common in isolated LMs, with 63.16% of patients exhibiting PIK3CA mutations. Conclusions: PIK3CA mutations are common in LM, supporting the potential for targeted therapies like PI3K inhibitors in treating complex cases. This research highlights the importance of genetic analysis in the management of LM and offers a new therapeutic approach.
- Open Access
Venous Malformations as a Rare Cause of Knee Joint Pain in Children and Young Adults: Clinical and Radiological Manifestations
Background: Venous malformations (VMs) are congenital vascular abnormalities characterized by tortuosity, slow blood flow, and gradual growth. Intra-articular venous malformations (IAVMs) of the knee are rare and often present with symptoms similar to juvenile idiopathic arthritis (JIA) or late sequelae of trauma. VM in children is commonly misdiagnosed as hemangioma. This study aims to analyze the clinical and MRI features of IAVM in the knee joint. Methods: This retrospective study analyzed patients from a reference unit for the treatment of vascular malformations in the Pediatric Surgery Department. The group was collected starting from the year 2014 until the 100th patient was identified in the year 2018, all with MRI-confirmed VM based on a predefined protocol. From this group, 19 patients with lower limb symptoms were identified, and 9 patients with VM involving the knee joint were selected for further analysis. Results: The most common symptoms in IAVM patients were pain and swelling, chronic in five (55%) and intermittent in four (45%). Four (45%) reported worsening pain during or after physical activity. A history of intra-articular bleeding was noted in five (55%), leading to mild knee contracture (10° reduction in extension) and decreased mobility. Limb deformities were observed in eight (89%). Diffuse VMs, affecting both intra- and extra-articular tissues, were present in eight (89%), involving the thigh in seven (78%), crus in five (56%), gluteal muscles in three (33%), and foot tissues in one (11%). The suprapatellar recess and Hoffa’s fat pad were involved in all patients (100%). Conclusions: IAVMs are rare causes of knee dysfunction in children and young adults, particularly in cases of unexplained pain, swelling, or instability. They should be considered in the differential diagnosis of hemophilic arthropathy, JIA, or late post-traumatic sequelae. Untreated IAVMs can lead to intra-articular bleeding, cartilage degeneration, and disability. Early diagnosis via MRI and ultrasound is crucial to identifying IAVMs and preventing joint degeneration. Timely treatment helps avoid further damage and long-term disability.
Open AccessVenous Malformations as a Rare Cause of Knee Joint Pain in Children and Young Adults: Clinical and Radiological Manifestations
Background: Venous malformations (VMs) are congenital vascular abnormalities characterized by tortuosity, slow blood flow, and gradual growth. Intra-articular venous malformations (IAVMs) of the knee are rare and often present with symptoms similar to juvenile idiopathic arthritis (JIA) or late sequelae of trauma. VM in children is commonly misdiagnosed as hemangioma. This study aims to analyze the clinical and MRI features of IAVM in the knee joint. Methods: This retrospective study analyzed patients from a reference unit for the treatment of vascular malformations in the Pediatric Surgery Department. The group was collected starting from the year 2014 until the 100th patient was identified in the year 2018, all with MRI-confirmed VM based on a predefined protocol. From this group, 19 patients with lower limb symptoms were identified, and 9 patients with VM involving the knee joint were selected for further analysis. Results: The most common symptoms in IAVM patients were pain and swelling, chronic in five (55%) and intermittent in four (45%). Four (45%) reported worsening pain during or after physical activity. A history of intra-articular bleeding was noted in five (55%), leading to mild knee contracture (10° reduction in extension) and decreased mobility. Limb deformities were observed in eight (89%). Diffuse VMs, affecting both intra- and extra-articular tissues, were present in eight (89%), involving the thigh in seven (78%), crus in five (56%), gluteal muscles in three (33%), and foot tissues in one (11%). The suprapatellar recess and Hoffa’s fat pad were involved in all patients (100%). Conclusions: IAVMs are rare causes of knee dysfunction in children and young adults, particularly in cases of unexplained pain, swelling, or instability. They should be considered in the differential diagnosis of hemophilic arthropathy, JIA, or late post-traumatic sequelae. Untreated IAVMs can lead to intra-articular bleeding, cartilage degeneration, and disability. Early diagnosis via MRI and ultrasound is crucial to identifying IAVMs and preventing joint degeneration. Timely treatment helps avoid further damage and long-term disability.
- Open Access
- 6 November 2024
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e946013
Life-Threatening Esophageal Variceal Hemorrhage in a 7-Year-Old Boy with Massive Portal Vein Enlargement Due to Congenital Arterioportal Fistula
Life-Threatening Esophageal Variceal Hemorrhage in a 7-Year-Old Boy with Massive Portal Vein Enlargement Due to Congenital Arterioportal Fistula - Article abstract #946013
- 6 November 2024
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e946013
Open AccessLife-Threatening Esophageal Variceal Hemorrhage in a 7-Year-Old Boy with Massive Portal Vein Enlargement Due to Congenital Arterioportal Fistula
Life-Threatening Esophageal Variceal Hemorrhage in a 7-Year-Old Boy with Massive Portal Vein Enlargement Due to Congenital Arterioportal Fistula - Article abstract #946013
- Open Access
- 25 December 2023
- Published by MDPI AG in Diagnostics
- Vol. 14 (1) , 38
mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age
Background: Vascular anomalies often result in aesthetic flaws, pain, and impair the quality of life. They require challenging treatments that frequently do not provide the desired results. The mammalian target of rapamycin (mTOR) is directly involved in the development of these malformations. However, the exact mechanism behind mTOR dysregulation has not been unambiguously defined. The purpose of this study is to investigate the activation of selected substrates of mTOR to partially assess its involvement in the disease process. Methods: We analyzed tissue samples collected from patients with vascular anomalies treated in our department. We included patients with histopathological diagnoses of lymphatic, venous, capillary malformations, mixed lesions, and a control group of healthy skin samples. We stained the samples using H and E and immunohistochemistry. We used primary antibodies against p70 S6 Kinase, 4EBP1, and p-4EBP1. We graded their color reactions. The statistical analyses were performed using the FactoMineR and factoextra R v.4.1 packages. p-values < 0.05 were considered statistically significant. Results: The analysis of 82 patients showed that healthy tissue vessels expressed lower levels of tested mTOR pathway substrates compared to high activation in vascular malformations. Elevated substrate expression in a comparison between sexes revealed higher P-4EBP1 expression in the female malformation group. We observed a decrease in mTOR substrate expression with age. Conclusion: The higher expression of mTOR substrates in vascular malformations compared to healthy tissue confirms their involvement in abnormal vascular development. Age-related changes in mTOR substrate expression highlight the need for timely intervention. Our study contributes to the understanding of the mTOR signaling pathway in vascular malformations and highlights its potential as a therapeutic target, contributing to personalized medicine.
- 25 December 2023
- Published by MDPI AG in Diagnostics
- Vol. 14 (1) , 38
Open AccessmTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age
Background: Vascular anomalies often result in aesthetic flaws, pain, and impair the quality of life. They require challenging treatments that frequently do not provide the desired results. The mammalian target of rapamycin (mTOR) is directly involved in the development of these malformations. However, the exact mechanism behind mTOR dysregulation has not been unambiguously defined. The purpose of this study is to investigate the activation of selected substrates of mTOR to partially assess its involvement in the disease process. Methods: We analyzed tissue samples collected from patients with vascular anomalies treated in our department. We included patients with histopathological diagnoses of lymphatic, venous, capillary malformations, mixed lesions, and a control group of healthy skin samples. We stained the samples using H and E and immunohistochemistry. We used primary antibodies against p70 S6 Kinase, 4EBP1, and p-4EBP1. We graded their color reactions. The statistical analyses were performed using the FactoMineR and factoextra R v.4.1 packages. p-values < 0.05 were considered statistically significant. Results: The analysis of 82 patients showed that healthy tissue vessels expressed lower levels of tested mTOR pathway substrates compared to high activation in vascular malformations. Elevated substrate expression in a comparison between sexes revealed higher P-4EBP1 expression in the female malformation group. We observed a decrease in mTOR substrate expression with age. Conclusion: The higher expression of mTOR substrates in vascular malformations compared to healthy tissue confirms their involvement in abnormal vascular development. Age-related changes in mTOR substrate expression highlight the need for timely intervention. Our study contributes to the understanding of the mTOR signaling pathway in vascular malformations and highlights its potential as a therapeutic target, contributing to personalized medicine.
- 13 October 2023
- Published by Index Copernicus in Polish Journal of Surgery
- Vol. 96 (SUPLEMENT ) , 13-16
Sequential, ultrasound-guided, minimally invasive pit-picking procedure with Nd:YAG laser epilation treatment for pilonidal disease
Aim: The aim of this retrospective study was to evaluate our treatment for pilonidal disease in adolescent patients, which uses ultrasonography, minimally invasive pit-picking, and Nd:YAG laser therapy. Material and methods: We included 52 of 147 patients treated between June 2017 and December 2020. The patients underwent pit-picking procedures and 6–10 Nd:YAG treatments. The remnants of the cysts were removed by laser therapy, which provided easy epilation. Each patient underwent multiple ultrasound examinations during the therapy to uncover any potential newly formed asymptomatic sinuses. When such issues were identified, the pit-picking procedure was repeated on those sinuses. Results: A total of 52 patients were included in this study with a 1-year follow-up following the procedure. There were 49 symptom-free patients (96%). One patient underwent surgery in another hospital because of a recurrence and 1 had a pilonidal disease relapse (4%). In the follow-up period, asymptomatic cysts were found in 2 other patients by ultrasound examination. They were all treated with a pit-picking procedure in the outpatient department with good results. Conclusions: Combining sequentially repeated pit-picking procedures and Nd:YAG laser therapy is an effective treatment method for adolescent pilonidal disease. Simultaneous Nd:YAG laser therapy enables efficacious epilation of the intergluteal cleft. Repeatable ultrasonography examinations allow for early diagnosis of possible pilonidal sinus relapse.
- 13 October 2023
- Published by Index Copernicus in Polish Journal of Surgery
- Vol. 96 (SUPLEMENT ) , 13-16
Sequential, ultrasound-guided, minimally invasive pit-picking procedure with Nd:YAG laser epilation treatment for pilonidal disease
Aim: The aim of this retrospective study was to evaluate our treatment for pilonidal disease in adolescent patients, which uses ultrasonography, minimally invasive pit-picking, and Nd:YAG laser therapy. Material and methods: We included 52 of 147 patients treated between June 2017 and December 2020. The patients underwent pit-picking procedures and 6–10 Nd:YAG treatments. The remnants of the cysts were removed by laser therapy, which provided easy epilation. Each patient underwent multiple ultrasound examinations during the therapy to uncover any potential newly formed asymptomatic sinuses. When such issues were identified, the pit-picking procedure was repeated on those sinuses. Results: A total of 52 patients were included in this study with a 1-year follow-up following the procedure. There were 49 symptom-free patients (96%). One patient underwent surgery in another hospital because of a recurrence and 1 had a pilonidal disease relapse (4%). In the follow-up period, asymptomatic cysts were found in 2 other patients by ultrasound examination. They were all treated with a pit-picking procedure in the outpatient department with good results. Conclusions: Combining sequentially repeated pit-picking procedures and Nd:YAG laser therapy is an effective treatment method for adolescent pilonidal disease. Simultaneous Nd:YAG laser therapy enables efficacious epilation of the intergluteal cleft. Repeatable ultrasonography examinations allow for early diagnosis of possible pilonidal sinus relapse.
- Open Access
- 23 February 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (4) , 2187
Respiratory Burst and TNF-α Receptor Expression of Neutrophils after Sepsis and Severe Injury-Induced Inflammation in Children
Systemic inflammatory response syndrome (SIRS) is defined as the systemic host response to infection or a non-infectious factor. The purpose of this study was to evaluate the involvement of reactive oxygen species (ROS) in severe inflammation and to assess the discrimination strength of the neutrophil BURSTTEST assay regarding its etiology in three groups of patients (sepsis, burns, and bone fractures) who met the SIRS criteria. The neutrophil activation (respiratory burst of granulocytes as well as p55 and p75 tumor necrosis factor (TNF-α) receptor expression) was evaluated twice using flow cytometry, and the results were compared with healthy controls and among SIRS subjects. A decreased oxygen metabolism in neutrophils after E.coli stimulation and increased TNF-α receptor expression were found in septic and burned patients on admission, while ROS production augmented and TNF-α receptor expression diminished with the applied therapy. The significant differences in neutrophil respiratory burst intensity among septic and burned patients and those with sepsis and bone fractures were found (however, there were not any such differences between patients with thermal and mechanical injuries). This study indicates that the neutrophil BURSTTEST evaluation might be a clinically reliable marker for differentiating the SIRS etiology.
- 23 February 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (4) , 2187
Open AccessRespiratory Burst and TNF-α Receptor Expression of Neutrophils after Sepsis and Severe Injury-Induced Inflammation in Children
Systemic inflammatory response syndrome (SIRS) is defined as the systemic host response to infection or a non-infectious factor. The purpose of this study was to evaluate the involvement of reactive oxygen species (ROS) in severe inflammation and to assess the discrimination strength of the neutrophil BURSTTEST assay regarding its etiology in three groups of patients (sepsis, burns, and bone fractures) who met the SIRS criteria. The neutrophil activation (respiratory burst of granulocytes as well as p55 and p75 tumor necrosis factor (TNF-α) receptor expression) was evaluated twice using flow cytometry, and the results were compared with healthy controls and among SIRS subjects. A decreased oxygen metabolism in neutrophils after E.coli stimulation and increased TNF-α receptor expression were found in septic and burned patients on admission, while ROS production augmented and TNF-α receptor expression diminished with the applied therapy. The significant differences in neutrophil respiratory burst intensity among septic and burned patients and those with sepsis and bone fractures were found (however, there were not any such differences between patients with thermal and mechanical injuries). This study indicates that the neutrophil BURSTTEST evaluation might be a clinically reliable marker for differentiating the SIRS etiology.
- Open Access
- 1 January 2021
- Published by Uniwersytet Warminsko-Mazurski in Polish Annals of Medicine
- p. 1-5
Fluid therapy in pyloric stenosis – assessment of the implementation of hospital guidelines
Introduction: The preoperative correction of the hypochloremic, hypokalemic metabolic alcalosis in children with infantile hypertrophic pyloric stenosis (IHPS) is essential to optimal outcome. Aim: The main aim of the study was the assessment of the implementation of hospital guidelines for intravenous fluid therapy in children with IHPS. Material and methods: In our Department, at the beginning of 2018 hospital guidelines for intravenous fluid therapy in children were implemented. Two internal audits were performed and surgeons’ compliance with the current recommendations was evaluated. We assessed: the type of fluid transfused, a rate of transfusion and whether saline bolus was given. The study group consisted of 50 patients. Results and discussion: After new guidelines were implemented, appropriate iv fluid was given to 68.7% of children compared to 5.1% before implementation (P = 0.0001). Proper transfusion rate was used in 44.1% of patients before introduction of new guidelines and in 81.2% after that (P = 0.01). Second audit showed that all children had received the recommended iv fluid (P = 0.007) at a good transfusion rate (P = 0.02). In patients who had received the recommended iv fluid, the length of hospital stay after surgery (P = 0.023) and the total length of stay (P = 0.018) were shorter. Conclusions: The new guidelines have raised the level of the whole care for children with pyloric stenosis. The internal audits played an important role in their implementation.
- 1 January 2021
- Published by Uniwersytet Warminsko-Mazurski in Polish Annals of Medicine
- p. 1-5
Open AccessFluid therapy in pyloric stenosis – assessment of the implementation of hospital guidelines
Introduction: The preoperative correction of the hypochloremic, hypokalemic metabolic alcalosis in children with infantile hypertrophic pyloric stenosis (IHPS) is essential to optimal outcome. Aim: The main aim of the study was the assessment of the implementation of hospital guidelines for intravenous fluid therapy in children with IHPS. Material and methods: In our Department, at the beginning of 2018 hospital guidelines for intravenous fluid therapy in children were implemented. Two internal audits were performed and surgeons’ compliance with the current recommendations was evaluated. We assessed: the type of fluid transfused, a rate of transfusion and whether saline bolus was given. The study group consisted of 50 patients. Results and discussion: After new guidelines were implemented, appropriate iv fluid was given to 68.7% of children compared to 5.1% before implementation (P = 0.0001). Proper transfusion rate was used in 44.1% of patients before introduction of new guidelines and in 81.2% after that (P = 0.01). Second audit showed that all children had received the recommended iv fluid (P = 0.007) at a good transfusion rate (P = 0.02). In patients who had received the recommended iv fluid, the length of hospital stay after surgery (P = 0.023) and the total length of stay (P = 0.018) were shorter. Conclusions: The new guidelines have raised the level of the whole care for children with pyloric stenosis. The internal audits played an important role in their implementation.
- 1 July 2016
- Published by Elsevier in Immunology Letters
- Vol. 175, 44-49
Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment
- 1 July 2016
- Published by Elsevier in Immunology Letters
- Vol. 175, 44-49
Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment